Susan H. Davis

Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against<i>Mycobacterium tuberculosis</i>

Yumi Park, A. Pacitto, Tracy Bayliss et al. · ACS Infectious Diseases · 2016 · 91 citations

Life Sciences, Molecular Biology, Pharmacology +13

Identification of Morpholino Thiophenes as Novel <i>Mycobacterium tuberculosis</i> Inhibitors, Targeting QcrB

Laura A. T. Cleghorn, Peter C. Ray, Joshua Odingo et al. · Journal of Medicinal Chemistry · 2018 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

Caroline Wilson, Peter C. Ray, Fabio Zuccotto et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

Simon R. Green, Susan H. Davis, Sebastian Damerow et al. · Nature Communications · 2022 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth

Peter C. Ray, Margaret Huggett, Penelope A. Turner et al. · ACS Omega · 2021 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13